Pharmacogenetics of the arylamine N-acetyltransferases
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 2 (1), 30-42
- https://doi.org/10.1038/sj.tpj.6500053
Abstract
The arylamine N-acetyltransferases (NATs) are involved in the metabolism of a variety of different compounds that we are exposed to on a daily basis. Many drugs and chemicals found in the environment, such as those in cigarette smoke, car exhaust fumes and in foodstuffs, can be either detoxified by NATs and eliminated from the body or bioactivated to metabolites that have the potential to cause toxicity and/or cancer. NATs have been implicated in some adverse drug reactions and as risk factors for several different types of cancers. As a result, the levels of NATs in the body have important consequences with regard to an individual's susceptibility to certain drug-induced toxicities and cancers. This review focuses on recent advances in the molecular genetics of the human NATs.Keywords
This publication has 112 references indexed in Scilit:
- Allelic Loss on Chromosome Arm 8p: Analysis of Sporadic Epithelial Ovarian TumorsGynecologic Oncology, 1999
- Cloning, Sequencing, and Recombinant Expression ofNAT1, NAT2,andNAT3Derived from the C3H/HeJ (Rapid) and A/HeJ (Slow) Acetylator Inbred Mouse: Functional Characterization of the Activation and Deactivation of Aromatic Amine CarcinogensToxicology and Applied Pharmacology, 1997
- Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamsterPharmacogenetics, 1996
- Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesisToxicology Letters, 1995
- Preliminary phenotypic map of chromosome 4p16 based on 4p deletionsAmerican Journal of Medical Genetics, 1995
- Intestinal microflora enhances formation of DNA adducts following administration of 2-NF and 2-AAFCarcinogenesis: Integrative Cancer Research, 1994
- Isolation and Mapping of a Cosmid Clone Containing the Human NAT 2 GeneBiochemical and Biophysical Research Communications, 1994
- N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cellsBiochemical and Biophysical Research Communications, 1992
- Acetylator Phenotype in Patients with Hydralazine‐induced Lupoid SyndromeActa Medica Scandinavica, 1976
- 14. Marts: Genetic factors in drug therapyNordisk Psykiatrisk Tidsskrift, 1969